A 2016 meta-analysis of 158 trials by Hazlewood and colleagues found that triple therapy with MTX, SSZ, and HCQ was more effective in preventing joint damage than MTX monotherapy. In contrast, no statistical difference in joint damage was found between patients treated with triple therapy versus those who received MTX coupled with a bDMARD or tsDMARD.
Learn more about combination therapies with csDMARDs.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Herbert S. Diamond. Fast Five Quiz: Rheumatoid Arthritis Management - Medscape - Jun 10, 2020.